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Summary
Clusters of Neisseria meningitidis (Nm) urethritis among primarily heterosexual males in multiple 
United States cities have been attributed to a unique non-encapsulated meningococcal clade (the 
U.S. Nm urethritis clade, US_NmUC) within the hypervirulent clonal complex 11. Resistance to 
antimicrobial peptides (AMPs) is a key feature of urogenital pathogenesis of the closely related 
species, N. gonorrhoeae. The US_NmUC isolates were found to be highly resistant to the model 
AMP, polymyxin B (PmB, MICs 64–256 μg/ml). The isolates also demonstrated stable 
subpopulations of heteroresistant colonies that showed near total resistant to PmB (MICs 384–
1024 μg/ml) and colistin (MIC 256 μg/ml) as well as enhanced LL-37 resistance. This is the first 
observation of heteroresistance in N. meningitidis. Consistent with previous findings, overall PmB 
resistance in US_NmUC isolates was due to active Mtr efflux and LptA-mediated lipid A 
modification. However, whole genome sequencing, variant analyses and directed mutagenesis 
revealed that the heteroresistance phenotypes and very high level AMP resistance were the result 
of point mutations and IS1655 element movement in the pilMNOPQ operon, encoding the type IV 
pilin biogenesis apparatus. Cross-resistance to other classes of antibiotics was also observed in the 
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heteroresistant colonies. High-level resistance to AMPs may contribute to the pathogenesis of 
US_NmUC.
Graphical Abstract
A unique meningococcal clade (US_NmUC) is causing urethritis clusters in multiple U.S. cities. 
US_NmUC isolates were resistant to the model antimicrobial peptide polymyxin B (PmB) and 
further expressed heteroresistant colonies highly resistant to PmB and colistin. Stable 
heteroresistance was caused by mutations and IS1655 insertions in the pilMNOPQ operon, which 
mediates the type IV pilin biogenesis, and conferred cross-resistance to other classes of antibiotics. 
This is the first observation of heteroresistance in N. meningitidis.
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Introduction
Neisseria meningitidis (Nm), an obligate human pathogen, is carried asymptomatically in 
the nasopharynx of 5–10% of adults and is transmitted by close contact with respiratory 
droplets of oral or nasal secretions. Nm is also a leading cause of meningitis and rapidly 
fatal sepsis in otherwise healthy individuals that can cause large epidemic outbreaks 
(Rouphael & Stephens, 2012, Stephens et al., 2007). While capsular polysaccharide 
conjugate and protein-based meningococcal vaccines provide protection, invasive 
meningococcal disease is a continued worldwide problem.
Nm and Neisseria gonorrhoeae (Ng) are the only two Neisseria species that are human 
pathogens and these organisms most commonly colonize respiratory and urogenital tracts, 
respectively. Historically, Nm has not been a significant cause of urogenital disease and was 
infrequently recovered from the urogenital tract (cervix, vagina, and urethra) and rectum. 
However, there have been sporadic case reports in which Nm was isolated from patients with 
urethritis, cervicitis, vaginitis, proctitis, pelvic inflammatory disease, and postpartum 
Tzeng et al. Page 2
Mol Microbiol. Author manuscript; available in PMC 2019 December 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
endometritis dating back to the 1940s (Givan et al., 1977, Conde-Glez & Calderon, 1991, 
Maini et al., 1992). Recently, sustained sexually transmitted meningococcal urethritis 
outbreaks have been reported (Bazan et al., 2016, Bazan et al., 2017, Toh et al., 2017, Tzeng 
et al., 2017, Retchless et al., 2018). In one study, seventy-five Nm urethritis cases detected 
between January and November of 2015 in Columbus OH, represented 20% of all men who 
presented during that time with urethral GNID and growth of oxidase-positive Gram-
negative diplococci (Bazan et al., 2017). Similar Nm-associated urethritis clusters have now 
been observed in multiple U.S. cities (Bazan et al., 2016, Bazan et al., 2017, Toh et al., 2017, 
Retchless et al., 2018). These urethritis-associated Nm isolates are members of a novel 
nongroupable US Nm urethritis clade (US_NmUC) in the cc11/ET-15 hyperinvasive lineage 
(Tzeng et al., 2017). The US_NmUC isolates do not make capsules (Toh et al., 2017, Tzeng 
et al., 2017) due to an IS1301 insertion that caused a multi-gene deletion at the capsule 
biosynthesis locus (Tzeng et al., 2017). Unlike many Nm isolates, the US_NmUC isolates 
are capable of efficient nitrite dependent anaerobic growth. This is due to a gene conversion 
event that introduced gonococcal aniA-norB genes, which encode enzymes that catalyze 
conversion of nitrite to nitric oxide and then nitrous oxide (Tzeng et al., 2017). Thus, the 
emergence of US_NmUC as a urethritis pathogen is likely the result of multiple evolutionary 
genetic events that allow better assimilation into the same niche first adopted by gonococci 
(Tzeng et al., 2017, Retchless et al., 2018).
Resistance to host-derived antimicrobial peptides (AMPs) is a key feature of neisserial 
pathogenesis at mucosal surfaces (Johnson & Criss, 2011, Tzeng & Stephens, 2015). A 
hallmark of gonococcal (and meningococcal) urethritis is the influx of PMNs, which employ 
both oxidative (production of reactive oxygen species) and non-oxidative (release of AMPs) 
killing mechanisms (Johnson & Criss, 2011, Criss & Seifert, 2012). In both Nm and Ng, 
resistance to PMN-derived and epithelial derived AMPs is mainly due to the activity of the 
LptA-mediated lipid A modification by phosphoethanolamine and the Mtr efflux pump 
(Tzeng et al., 2005). We have previously performed mariner random mutagenesis screening 
and identified transposon mutants in pilM and pilP that increased AMP resistance (Tzeng et 
al., 2005). In this report we show that the US_NmUC isolates are highly resistant to the 
AMP polymyxin B (PmB), a well-recognized surrogate for endogenous AMPs, and also 
exhibit “heteroresistance” (subpopulations of higher resistant colonies in the zone of 
inhibition) to PmB and colistin (polymyxin E). Increased AMP resistance of these isolates is 
linked to mutations in pilM and pilQ. PilQ is a member of the secretin family of proteins, 
and a major component of the outer membrane (Berry et al., 2012). PilM is a cytoplasmic 
ATP-binding protein that together with PilN/O/P proteins forms the inner membrane 
platform of the type IV pilus biogenesis complex (Ayers et al., 2009). Nm heteroresistance 
selected by PmB exposure, in addition to enhance resistance to colistin and LL-37, also 
conferred cross-resistance to several antibiotics, suggesting entry of these antibiotics is PilQ 
dependent. Heteroresistance to PmB has been described in several other Gram-negative 
bacterial pathogens, (Li et al., 2006, Lo-Ten-Foe et al., 2007, Hermes et al., 2013, Hjort et 
al., 2016, Jayol et al., 2015, El-Halfawy & Valvano, 2013) but this is the first demonstration 
of this phenomenon in Neisseriae.
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Results
US_NmUC isolates demonstrate heteroresistance to polymyxin B and colistin
AMP resistance is an important pathogenic trait for both Ng and Nm. PmB E-test strips were 
used to determine the PmB MICs and revealed that the non-encapsulated US_NmUC 
isolates were highly resistant (Supplemental Table S1; Figure 1A). Of 52 CNM isolates, 41 
(79%) had PmB MIC of 128–256 μg/ml and MICs of 10/11 remaining isolates were 64–96 
μg/ml. One isolate, CNM34, had a significantly lower PmB MIC (16 μg/ml). Whole genome 
analysis of this isolate revealed a 2-bp deletion in mtrC, which encodes a key component of 
the Mtr efflux pump (Shafer et al., 1998). Two US_NmUC isolates from Atlanta had MICs 
of 96 and 128 μg/ml, respectively (Table S1). For comparison, the PmB MIC of a well-
characterized unencapsulated meningococcal M7 strain (Swartley & Stephens, 1994, Tzeng 
et al., 2005) is 64 μg/ml. The PmB MICs of a clinical gonococcal isolate recovered during 
the Columbus urethritis outbreak (CNG20) and two gonococcal reference strains (FA19 and 
FA1090) were 48, 48 and 96 μg/ml, respectively; while the PmB MIC of a multi-drug 
resistant (MDR) gonococcal isolate from Japan, H041, (Ohnishi et al., 2011) is 192 μg/ml. 
These data suggest that the non-encapsulated US_NmUC isolates display equal or greater 
AMP resistance than gonococci.
Many of the US_NmUC isolates displayed PmB heteroresistance (Li et al., 2006, Lo-Ten-
Foe et al., 2007); i.e., they yielded subpopulations of highly PmB resistant colonies in the 
zone of inhibition in disc diffusion and E-test assays (e.g. CNM3 shown in Figure 1A). 
These isolates also yielded higher MIC values in microbroth dilution assays. For example, 
the PmB MIC of CNM3 was 256 μg/ml by E-test, but was 1,024 μg/ml using the microbroth 
dilution assay. In contrast, neither the gonococcal strains tested nor M7 exhibited 
heteroresistance. However, during E testing, we did observe heteroresistant colonies of 
FAM18, a serogroup C cc11 reference strain, and a serogroup W cc22 invasive isolate 
GA18736 from Georgia (E-test pictures shown in supplemental figure 1), indicating that 
heteroresistance in Nm is not only found in US_NmUC isolates.
Heteroresistance of the US_NmUC isolates was confirmed using population analysis 
profiling (PAP) assays (El-Halfawy & Valvano, 2015). CNM3, CNM8 and the non-
encapsulated FAM18 derivative FM7 was not eliminated by > 16-fold increases in PmB 
concentration (Figure 1B). In contrast, growth inhibition of M7 and FA1090 occurred across 
a narrow PmB concentration range. MC58 and FA19 also did not exhibit heteroresistance 
(data not shown). Interestingly, although CNM8 and FM7 failed to form colonies in the zone 
of inhibition in E tests (Figure 1A), these strains were heteroresistant in the PAP assay 
(Figure 1B).
We also examined whether the isolates exhibiting PmB heteroresistance would display 
analogous phenotypes toward another clinically used AMP, colistin (polymyxin E). As 
shown in Figure 1C, CNM3 and FM7 displayed the heteroresistance profile toward colistin; 
while the growth of M7 and FA1090 was inhibited across a narrow range. These data were 
consistent with the PmB resistance profiles of these strains. Further, the colistin E-test of 
CNM3 also showed colonies within the zone of inhibition (insert in Fig. 1C).
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Heteroresistance to PmB is stable in US_NmUC isolates
Heteroresistance to PmB, colistin and other antimicrobial agents in some bacteria is transient 
and reverts in the absence of continuous antimicrobial pressure (Napier et al., 2014, El-
Halfawy & Valvano, 2015). To test if heteroresistance in the US_NmUC isolates was 
reversible, colonies picked from the zones of inhibition of CNM isolates (Table 1) were 
repeatedly passed on GCB agar plates in the absence of PmB. The elevated PmB MICs of 
these colonies were retained, suggesting that their enhanced PmB resistance was stable and 
likely due to genetic change(s). One of the recovered heteroresistant mutants, 3R4, was 
examined for resistance to colistin using PAP and E-test. The mutant was more resistant to 
colistin with a MIC greater than 256 μg/ml, whereas the MIC of the parental isolate CNM3 
to colistin was ~ 48–64 μg/ml (Figure 1C). The resistance to LL-37 was also compared. The 
strains were treated with varying concentrations of LL-37 for 30 min followed by plating for 
viable CFU counts. The 3R4 mutant was more resistant to LL-37 in all concentrations tested 
than the parental strain (Figure 2), thus supporting the hypothesis that PmB heteroresistance 
confers cross-resistance to host endogenous antimicrobial peptides.
Identification of heteroresistance associated mutations using genome sequencing
Genomes of eight heteroresistant colonies (3R3, 14R2, 17R1, 32R1, 32R2, 33R1, 37R1 and 
45R2) derived from 7 CNM isolates (first number in strain designation is the parental CNM 
number, Table 1) were sequenced. Variants were identified by aligning the raw sequence 
reads against a CNM10 reference genome using PATRIC (www.patricbrc.org). Separately, 
assembled contigs were also compared to the CNM10 genome using the genome comparator 
(www.pubmlst.org).
Variants (Supplemental Data set S1) were examined for genes with previously reported roles 
in antimicrobial resistance. Alterations in several pil genes were identified in multiple 
heteroresistant mutants, pilU (33R1), pilM (45R2), pilQ (14R2, 17R1) and the pilS cassettes 
(silent incomplete pilin coding fragments responsible for antigenic variation of PilE) (17R1, 
32R1, 32R2, 33R1 and 37R1) (Supplemental Data set S1). The class II pilE gene encoded 
near katA was intact in all mutants. Multiple repeated sequence motifs and slipped strand 
mispairing (SSM) events were detected, but none of these were in loci with known roles in 
AMP resistance. Overall, point mutations in pilM or pilQ were identified in seven of the 
eight heteroresistant mutants; while pilM is disrupted by an IS element in the remaining 
mutant (Table 1).
Frameshift mutations were identified in pilQ in the 3R4, 32R1, 32R2 and 33R1 mutants. 
3R4 had a deletion (T) at position 167 that resulted in a premature stop at residue 57. Five 
additional colonies recovered from CNM3 (3R4–3R7) in independent experiments had the 
same deletion. 32R1 and 32R2 were isolated from CNM32 and both had a 1-bp insertion (G) 
at position 2229 that extended the PilQ coding region (815 aa vs. 769 aa). 33R1 had a 1-bp 
deletion (A) at position 1947 that truncated PilQ from 769 to 655 residues. The insertion in 
32R1 changed a G3 to a G4 track and the deletion in 33R1 resulted in an A6-to-A5 transition. 
Whether these two short homopolymeric tracks have an increased sequence instability 
associated with the slipped strand mispairing phase variation events is not clear (Saunders et 
al., 2000, Snyder et al., 2001). The 14R2 and 17R1 mutants had C-A conversions at 
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positions 2266 and 1465 that resulted in T to P residue changes at residue 756 and 489, 
respectively. Since the pilQ frameshift and these missense mutations yielded high levels of 
PmB resistance (MIC 1,024 μg/ml), these observations suggest that the missense mutations 
in 14R2 and 17R1 likely disrupt PilQ’s function as a multimeric protein complex. Two 
mutants had mutations in pilM, the first gene in the pilMNOPQ operon (Carbonnelle et al., 
2005). 45R2 had a C-T conversion that resulted in a stop codon at residue 44; while pilM in 
37R1 was disrupted by an IS1655 insertion at position 16. The pilM mutants had lower PmB 
MICs (256–512 μg/ml) than the pilQ mutants.
To further evaluate the effects of various pilQ and pilM mutations, we performed PilQ 
Western blots on total cellular extracts of the heteroresistant mutants and the wild type 
strain. As shown in Figure 3, a high molecular weight multimer band, a monomer band and 
several smaller bands, presumably degraded products, were detected by the PilQ monoclonal 
antibodies, like the previously reported pattern (Nandi et al., 2015). The pilQ frameshift 
mutants (3R4 and 33R1) resulting in premature truncation eliminated both of multimer and 
monomer bands (lanes 2 and 8). A weak and larger monomer band was detected for 32R1 
(lane 7), in which the frameshift mutation resulting in a predicted larger protein; however, no 
multimer band was detected in this mutant. Two mutants with pilQ T to P residue changes 
(14R2 and 17R1) yielded no multimer bands, while maintaining monomer bands at 
comparable intensities as the wild type strain (lanes 5 and 6). Finally, the pilM::IS1655 
mutant (37R1) and the pilM frameshift mutant (45R2) showed reduced levels of PilQ in both 
multimer and monomer forms (lanes 3 and 4), indicating a probable polar effect on PilQ 
protein expression, a phenomenon also observed in gonococci (Nandi et al., 2015).
Independent pilM and pilQ mutations conferred enhanced PmB resistance
We previously showed that separate mariner transposon mutants in pilM and pilP caused 
increased PmB resistance (Tzeng et al., 2005). Transferring the pilM::aphA3 mutation into 
CNM3 was sufficient to increase the PmB MIC and the introduction of pilQ::aphA3 into 
CNM3 also conferred the higher PmB MICs observed in pilQ frame shift mutants. To 
independently confirm the effects of pilQ T→P point mutations, constructs with the 
aphA3(KnR) cassette inserted immediately downstream of the pilQ stop codon and carrying 
14R2 or 17R1 point mutations in pilQ were generated. Five transformants were sequenced. 
All five CNM3–14R2 transformants carried the expected mutation via homologous 
recombination, whereas 2 of 5 CNM3–17R1 transformants contained the desired mutation. 
E-tests confirmed that the transformants carrying the T→P mutation have enhanced PmB 
resistance (Supplemental Figure 1), while PmB MICs of the transformants with a wild type 
pilQ sequence were identical to that of CNM3. Introducing these mutations in the respective 
parental isolate (CNM14 and CNM17) also produced the same PmB resistance results as the 
original mutants.
The pilM and pilQ mutations reduced transformation efficiency
Disruption of type IV pilin biogenesis apparatus is known to cause competence deficiency 
(Georgiadou et al., 2012). Thus, we expected the PmB heteroresistant mutants to have 
defects in transformation efficiency. Transformation efficiencies of the mutants were 
examined using chromosomal DNA carrying a tonB::Ω(Sp) mutation. As show in Table 1, 
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all parental isolates showed transformation efficiency in the range of 10−4 – 10−5 per μg 
DNA. Significant reductions (>3 logs) were observed in all PmB resistant mutants. Most of 
the mutants were not transformable. The 17R1 (PilQ/T489P) mutant and the 33R1 mutant 
with a truncated PilQ remained transformable but with a 2-order of magnitude reduction in 
efficiency. Despite the differences in transformation efficiency, all pilQ mutations yielded 
similar higher levels of PmB resistance than the pilM mutants, both mutants were 
incompetent in transformation. There was no correlation between PmB resistance and 
transformation phenotypes.
Heteroresistance requires the Mtr efflux pump and the LptA transferase
N. meningitidis intrinsic PmB resistance is mediated by LptA-mediated lipid A modification 
with phosphoethanolamine, the Mtr efflux pump and the capsule (Tzeng et al., 2005, 
Spinosa et al., 2007, Jones et al., 2009). To test if heteroresistance required these 
mechanisms, we introduced mtrD or lptA mutations in CNM3. Inactivation of mtrD and 
lptA reduced the PmB MIC levels to 24–32 μg/ml and 0.1 μg/ml, respectively (E-test data 
shown in supplemental figure 1). Neither mutants formed heteroresistant colonies in E-test 
and disc diffusion assays. In addition, PAP assays showed no heteroresistance toward PmB 
or colistin in the mtrD mutant (CNM3D) (Figure 4). Thus, development of heteroresistance 
in these strains is dependent upon intrinsic determinants of PmB resistance (Tzeng et al., 
2005).
The US_NmUC isolates did not have higher spontaneous mutation or slipped strand 
mispairing frequencies
The number of point mutations and changes in monomeric tracks we observed suggested 
that the heteroresistant isolates might have higher mutation rates. We examined the 
spontaneous mutation rate in CNM3 using rifampin plating assays. The spontaneous 
rifampin resistance rate of CNM3 was low (median 2.2×10−10) and comparable to a low 
switcher strain IR2781 (median 1.7×10−9) (Richardson & Stojiljkovic, 2001). For 
comparison, IR2855, a mutL mutator strain that has a ~1000-fold higher mutation rate 
(median 3.7×10−7) than CNM3, exhibited a PAP profile similar to CNM3 (Figure 4A). The 
DNA mismatch repair (MMR) pathway is an important determinant of overall mutability 
and phase variation frequency in Nm (Richardson & Stojiljkovic, 2001). We generated a 
mutL mutation in CNM3 (CNM3L) to test if heteroresistance was influenced by the MMR 
pathway. The spontaneous rifampin resistance rate in CNM3L was more than 100-fold 
higher compared to CNM3 but these strains had similar PAP profile (Figure 4A). Thus, the 
MMR system did not appear to have a major role in the PmB heteroresistance phenotype.
Interestingly, it has been reported that cationic antimicrobial peptides, LL-37 and colistin, 
increased iron-induced mutagenesis in P. aeruginosa (Limoli et al., 2014, Rodriguez-Rojas et 
al., 2015). As we have performed experiments using iron-rich GC media, it was plausible 
that the heteroresistant mutations were enhanced in the presence of PmB and possibly other 
AMPs in N. meningitidis. We examined whether the antimicrobial peptide affected 
mutagenic phenotype in the clade isolate by comparing spontaneous rifampin mutation rates 
of meningococci grown on standard GC plates (Fe+3 is supplemented at 12 μg/ml) with or 
without colistin at 128 or 256 μg/ml (MIC50 as determined by the PAP assay is ~128 μg/ml). 
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When compared to meningococci grown in the absence of colistin, no significant increases 
in spontaneous rifampin mutation rates upon exposure to colistin under the iron-replete 
condition were observed (data not shown).
We also measured the frequency of slipped-strand mispairing using the universal rate of 
switching cassette (UROS) assay (Alexander et al., 2004b). The UROS cassette contains a 
poly (G)8 tract within the Ω(Sp) cassette of aadA that is in the off phase. Thus, SpR colonies 
form when aadA is switched into the on phase by slipped strand mispairing. The UROS 
cassette did not show a higher slipped strand mispairing rate in CNM3, when compared to 
that of strain IR5426, (UROS cassette in the high switcher/mutator IR2855) (Alexander et 
al., 2004b).
PmB heteroresistant mutants have reduced susceptibility to multiple antibiotics
We tested if the resistance to other antimicrobial agents was altered in the PmB 
heteroresistant mutant 3R4, using E-tests (Table 2) and disc diffusion (supplemental table 2) 
on GC agar plates. CNM3 and 3R4 had similar susceptibility to levofloxacin, meropenem 
and azithromycin, which is one of the two current standards of care antibiotic treatment for 
gonorrhea. However, 3R4 has reduced susceptibility to penicillin G, ceftriaxone, cefotaxime, 
streptomycin, kanamycin, chloramphenicol and tetracycline (Table 2). The resistances of 
3R4 to ceftriaxone and cefotaxime were two-fold higher than CNM3 by E-test, although its 
MICs remained in the sensitive range (Table 2). Interestingly, CNM3 has reduced 
susceptibility to several antibiotics such as azithromycin, meropenem, penicillin, and 
cefuroxime when compared to the Ng reference strain FA19 and to a clinical isolate CNG20. 
The resistance of CNM3 to penicillin G, cefuroxime and azithromycin was like that of the 
gonococcal isolate MS11, which has elevated resistance due to the presence of the penA, 
mtrR, and penB mutations (Ropp et al., 2002, Ohneck et al., 2011). Thus, the pilQ defect in 
the PmB heteroresistant mutant indeed influenced, albeit modestly, the susceptibility to 
many unrelated antibiotics.
Altered resistances to penicillin G, chloramphenicol and tetracycline between CNM3 and 
3R4 were also compared in the mtrD and the lptA mutant backgrounds and no differences 
were observed in these backgrounds (Table 3). These data suggest that the higher 
intracellular antibiotic levels caused by either efflux pump inactivation (mtrD) or 
compromised membrane integrity (lptA) cannot be effectively reduced by blocking 
antibiotic entry through a pilQ mutation.
Discussion
The US_NmUC has emerged as urogenital pathogen. Historically, Nm is not recognized as a 
significant cause of urogenital infection and the occasional meningococci recovered from 
such isolated cases have been from diverse serogroups and lineages (Harrison et al., 2017, 
Ma et al., 2017). The recent urethritis outbreaks and clusters caused by US_NmUC suggest 
that with novel genetic and phenotypic changes, this meningococcal clade is being 
transmitted efficiently between sexual partners and can successfully resist local innate 
immune responses (Bazan et al., 2016, Tzeng et al., 2017, Bazan et al., 2017, Toh et al., 
2017, Retchless et al., 2018).
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Like N. gonorrhoeae, the US_NmUC isolates trigger a potent local inflammatory response 
characterized by urethral discharge and presence of many polymorphonuclear leukocytes 
(PMNs) in the inflammatory exudates (Johnson & Criss, 2011). These US_NmUC isolates 
exhibited bacterial resistance to host killing. In this report, we investigate the basis of high-
level resistance to AMPs of these US_NmUC isolates. Resistance to host-derived AMPs is 
an important pathogenic trait for both Ng and Nm (Johnson & Criss, 2011). Recent studies 
have indicated that PMNs primarily direct non-oxidative antimicrobial activities against Ng 
(Johnson & Criss, 2011). Non-encapsulated Nm and Ng are generally more sensitive to the 
action of AMPs than encapsulated meningococci (Tzeng et al., 2005). The ability of US 
NmUC isolates to resist killing by human AMPs, either produced locally by the mucosal 
epithelia where they serve as a primary defense mechanism or to resist AMP-mediated non-
oxidative killing by PMNs at this site, may have important advantages. Survival in PMN’s 
may also serve as vehicles for dissemination in urethral exudates. Many of the non-
encapsulated US_NmUC isolates displayed greater PmB resistance (MICs 96–256 μg/ml) 
than Ng and considerable higher resistance (MICs 384–1,024 μg/ml) was observed for the 
heteroresistant subpopulations.
Heteroresistance to PmB or colistin has been described in Acinetobacter baumannii (Li et 
al., 2006), Enterobacter cloacae (Lo-Ten-Foe et al., 2007), P. aeruginosa (Hermes et al., 
2013), Salmonella typhimurium (Hjort et al., 2016), Klebsiella pneumonia (Jayol et al., 
2015, Band et al., 2018) and Burkholderia cenocepacia (El-Halfawy & Valvano, 2013) and 
can lead to treatment failure in clinical settings and in experimental models (Band et al., 
2016, Band et al., 2018). Interestingly, the PmB heteroresistant subpopulation of B. 
cenocepacia can protect the more sensitive B. cenocepacia population as well as sensitive P. 
aeruginosa and Escherichia coli from killing by PmB and various bactericidal antibiotics 
(El-Halfawy & Valvano, 2013). However, heteroresistance to AMPs has not been previously 
reported for Neisseria. Further, we found that meningococcal heteroresistance was not 
transiently induced upon exposure to AMPs (Napier et al., 2014), but was instead stable in 
the absence of PmB, and we have identified the genetic alteration(s) aiding PmB resistance.
Mutations in the pilin biogenesis apparatus appear to restrict the entry of PmB and other 
antimicrobial agents, and responsible for heteroresistance in Nm. PilQ secretin, in addition 
to promoting pilin biogenesis and DNA transformation, facilitates the entry of small 
molecules into the bacterial cell. High-level heteroresistance to PmB can produce cross-
resistance to several other important antimicrobial agents [Table 2 and (Napier et al., 2014)]. 
The increase in MICs of PmB and to a variety of antibiotics in the heteroresistant mutants 
compared to the wild type strain are consistent with those observed in gonococcal pilQ 
mutants (Chen et al., 2004, Zhao et al., 2005, Johnson et al., 2014), highlighting the 
importance of a functional PilQ in the entry of antibiotics.
PilQ facilitates the entry of a variety of antibiotics in the gonococci, including penicillin, 
ceftriaxone, vancomycin, tetracycline, rifampin, and ciprofloxacin (Ropp et al., 2002, Zhao 
et al., 2005, Nandi et al., 2015). An in vitro spontaneous mutation screen of two gonococcal 
isolates containing mosaic penA sequence with MICs to ceftriaxone ranging from 0.03 to 
0.06 μg/ml identified mutants with increased MICs to ceftriaxone almost 10-fold (0.5 μg/
ml). Genetic analysis showed an identical 2-bp insertion in pilQ in each of the mutants 
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(Johnson et al., 2014). Further, spontaneous penicillin resistant gonococcal clones were 
selected at a frequency of ~10−6 and all had a non-piliated morphology (Nandi et al., 2015). 
The mutations were found to be clustered within the C-terminal domain (residue 400 to 731) 
of PilQ and all pilQ mutants increased the MIC of penicillin by 2.5- to 3-fold (Nandi et al., 
2015).
Of the five gene mutations known to contribute to high-level penicillin resistance in Ng 
(Ropp et al., 2002), penB, mtrR and pilQ2, have been shown to also play a role in PmB 
susceptibility (Tzeng et al., 2005). The pilQ2 allele is an E666K point mutation in pilQ 
(Zhao et al., 2005). Interestingly, the increased resistance due to acquisition of the pilQ2 
mutation is observed only in strains containing the mtrR and penB resistance determinants 
(Zhao et al., 2005). The diffusion of antibiotics through PilQ become significant only when 
influx through porins is limited due to disruptions in the porin gene (penB) or up-regulation 
of Mtr pump efflux (mtrR), (Zhao et al., 2005). Similarly, diffusion of antibiotics through 
PilQ is likely only a small fraction of the antibiotic influx in N. meningitidis, as reflected by 
the modest changes in MIC values in the heteroresistant mutants. We observed that the pilQ 
mutations caused enhanced PmB resistance only in the wild type background. When 
resistance levels were reduced ~4–8 fold by mutations in the Mtr efflux pump, we did not 
observe any clear difference in PmB resistance with the combined pilQ/mtr mutation.
Defects in the mismatch repair (MMR) pathway responsible for removing insertion/deletion 
loops (Lahue et al., 1989) have generally been associated with meningococcal mutator 
phenotype (Richardson & Stojiljkovic, 2001, Richardson et al., 2002). Since PmB resistant 
mutants due to frameshift and point mutations in pilQ and pilM were recovered readily from 
the heteroresistant clade isolates, a possible mutator phenotype and a defect in MMR 
pathway was explored. Nevertheless, the clade isolates did not show enhanced mutation rate 
using the standard spontaneous rifampin resistance plating assay and have relatively low 
slipped strand mispairing rates. We examined the contribution of the MMR pathway by 
introducing a mutL mutation, and confirmed that no effect on heteroresistance was detected 
in the mutL mutant. However, the standard rifampin plating assay that measures the 
spontaneous mutation rate in the essential rpoB gene, encoding a subunit of RNA 
polymerase, is likely constrained to only detect the rate yielding viable mutants. Thus, it is 
possible that the mutation rates obtained with rifampin resistance do not reflect the rates of 
those mutations needed for antimicrobial peptide resistance. Antimicrobial peptides such as 
colistin and LL-37 have been reported to enhance mutation rates in P. aeruginosa (Limoli et 
al., 2014, Rodriguez-Rojas et al., 2015). However, we did not detect significant changes in 
rifampin mutation rates when meningococci were grown on iron-rich GC agar plates in the 
presence of colistin, a condition shown to influence mutagenic phenotype in P. aeruginosa 
(Rodriguez-Rojas et al., 2015).
Other repair pathways correcting DNA lesions include the base excision repair (BER) 
(MutY, Fpg/MutM, Nth), the nucleotide excision repair (NER) (UvrA/B/C), the 
recombinational repair (RecA/B/C/D), and translesion synthesis (DinB) (Davidsen et al., 
2007b). Several of these DNA repair proteins and others have been characterized to 
influence mutation rates (Alexander et al., 2004a, Martin et al., 2004, Davidsen et al., 2007b, 
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Davidsen et al., 2007a), thus additional studies are needed to have a detailed understanding 
about the contribution of other DNA repair pathways in the development of heteroresistance.
The 37R1 heteroresistant mutant had a pilM disruption by a newly inserted IS1655. IS1655 
is a 1080-bp long element that would generate a 3-bp target duplication upon insertion (Kiss 
et al., 2007), which was indeed observed in 37R1. A whole genome comparison study of 
disease and carriage strains has suggested that Nm can be separated from Neisseria 
lactamica and Ng based on the respective IS repertoires and that IS1655 is restricted to Nm 
(Schoen et al., 2008). The authors noted that none of the six Nm strains analyzed have 
IS1655 at the same chromosomal location, suggesting a high mobility of IS1655. Inspecting 
the complete genome of the US_NmUC isolate CNM10, we found 11 intact copies and one 
truncated copy of IS1655. As a comparison, the serogroup B strain MC58 has 14 copies; 
while the cc11 reference FAM18 has 9 intact and 1 truncated copies. Since the genome of 
37R1 had multiple contig breaks, it is uncertain whether 37R1 has the same copy number of 
IS1655 as CNM10.
Because the pilin biogenesis mutations disrupt normal piliation, the increases in AMP 
resistance because of such mutations might not be biologically significant, considering the 
importance of pili in colonization and infections. However, mutations in pilQ have been 
shown to result in complex phenotypes (Helm et al., 2007), it is possible that certain pilQ 
mutations allow for increased AMP resistance and retain pathogenic potential. Interestingly, 
experimental infections of male volunteers using a nonpiliated gonococcal pilE mutant 
showed that the pilus was not required for infection, although the symptoms were less severe 
in infections with the nonpiliated variant (Hobbs et al., 2011).
Ng has been proposed to have originated from Nm, a pharyngeal colonizer that switched to 
primarily colonizing the urogenital tracts, resulting in lower frequency of gene flow between 
Nm and Ng due to ecological separation within the human host (Vazquez et al., 1993). The 
ability of US_NmUC isolates to withstand killing by AMPs produced either by epithelial 
cells or by PMNs is likely an important selective advantage and requirement for 
dissemination in urethral exudates. Further, the ability of the clade isolates to effectively 
colonize the urogenital tract raises the concern of horizontal gene transfer of antimicrobial 
resistance determinants, considering the wide-spread antimicrobial resistance in Ng (Unemo 
& Shafer, 2014). US_NmUC isolates are intermediate in sensitivity to penicillin, sensitive to 
azithromycin and ceftriaxone and have uniformly responded to gonococcal treatment 
regimens. However, the heteroresistance phenotype further demonstrates the propensity for 
enhanced antibiotic resistance by spontaneous mutations of the pilin biogenesis genes and/or 
IS movement in this clade. Based on emergence of antibiotic resistance in the gonococcus, 
we will continue to need to monitor the antimicrobial resistance of this novel meningococcal 
urethritis clade.
Experimental Procedures
Bacterial isolates and growth conditions
Bacterial strains used in this study are listed in Table 4. These stains included 52 N. 
meningitidis urethritis clade isolates collected from men between January 2015 and 
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September 2015 at Columbus Public Health (CPH), Columbus, Ohio (Tzeng et al., 2017) 
with the CNM3 isolate being the major representative of this collection. The initial 
demographic features of these cases and the collection protocol have been previously 
reported (Bazan et al., 2016, Bazan et al., 2017). Two additional clade isolates from Atlanta, 
Georgia, ATL#1 and ATL#2, a serogroup A isolate, IR2855, a serogroup W clinical isolate, 
GA18736, as well as genetically defined derivatives of well-characterized N. meningitidis 
strains IR2781 (NMB) (Stephens et al., 1991) and FAM18 were also used. One gonococcal 
isolate (CNG20) recovered from the same period and gonococcal reference strains, FA19, 
FA1090, MS11 and H041 were also used for comparisons. Neisseria were cultured with 5% 
CO2 at 37°C on GC base (GCB; Difco) agar containing supplements of 0.4% glucose and 
0.68 mM Fe(NO3)3, or GC broth with the same supplements and 0.043% NaHCO3. Brain 
heart infusion (BHI) medium with 1.25% fetal bovine serum was used when kanamycin 
selection was required. Escherichia coli strains were routinely grown in Luria Bertani broth 
for cloning and propagation of plasmids. N. meningitidis was transformed by the procedure 
of Janik et al. (Janik et al., 1976). E. coli strains were transformed by chemical competence 
or by electroporation with a GenePulser (Bio-Rad) according to the manufacturer’s protocol. 
When necessary, Neisseria (E. coli) were grown in the presence of antibiotic concentrations 
(μg/ml): kanamycin (Kn) 80 (50), chloramphenicol, 5 (34), tetracycline, 5 and 
spectinomycin (Sp), 60 (100).
Susceptibility assays
The minimum inhibitory concentrations of PmB and antibiotics were determined by E test. 
Cell suspensions from overnight GC plates adjusted to OD550 of 0.3 were swabbed onto GC 
agar plates. Discs soaked with 10 μl of PmB solutions (25.6 mg/ml) or discs with defined 
levels of antibiotics (BBL) were overlaid and the plates were incubated overnight at 37°C in 
5% CO2. E test strips (bioMerieux) were performed in a similar fashion. MIC values of PmB 
were reported as μg/ml. Microbroth dilution assays using 96-well microtiter plates were 
performed using GC broth with standard supplements. Two-fold serial dilutions of PmB 
concentrations starting at 1,024 μg/mL were tested. The sensitivity to LL-37 was determined 
using 96-well microtiter plate.
Population analysis profiling (PAP) assays
Overnight plate cultures of meningococcal strains were resuspended in GC broth and 
adjusted to optical density of 0.3 at 550 nm. Ten-fold serial diluted bacterial suspensions 
were prepared and duplicate aliquots of 40 μl of suspensions were spotted onto GC agar 
plates with 2-fold incremented concentrations of polymyxin B. Bacterial growth at each of 
these concentrations is quantified by CFU count after overnight incubation. An isolate would 
be considered heteroresistant when the lowest antibiotic concentration giving maximum 
growth inhibition is >8-fold higher than the highest non-inhibitory concentration (El-
Halfawy & Valvano, 2015).
Western blot
Expression of PilQ in whole-cell extracts was examined by Western blot. Briefly, strains 
grown on GC plates overnight at 37°C were collected by centrifugation. Whole cell lysates 
of equal cell densities were prepared in SDS loading buffer, resolved by 8% SDS-PAGE, and 
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transferred to nitrocellulose membranes by semi-dry transfer. The antisera against PilQ 
(Tonjum et al., 1998) were used at 1:5000 dilutions and anti-rabbit IgG-HRP conjugate 
secondary antibody (Bio-Rad) was used at 1:10,000 dilution. The blot was developed using a 
1:5 dilution of pico chemiluminescent substrate (Pierce).
LL-37 killing assay
Overnight cultures were harvested into RPMI and adjusted to OD550 of 0.3. The 
standardized suspensions were diluted 100-fold and then 50-fold to have approximately 105 
CFU/ml. Each assay was started by the addition of 90 μl of cells into a well containing 10 μl 
of LL-37 to reach the desired final concentrations, 1.25 to 10 μg/ml. The microtiter plate was 
incubated at 37°C and 5% CO2. Two 20-μl aliquots of the sample were removed after 30 
min and the number of viable CFU were determined by plating onto GC agar plates. 
Experiments were performed in duplicate wells on several occasions. Student’s t test was 
used to determine the statistical significance of survival of the mutant with respect to that of 
the wild type strain, with P values of < 0.05 considered significant.
Whole genome sequencing (WGS) and variant analysis
WGS of all 52 CNM isolates has been performed by Illumina at CDC (Tzeng et al., 2017). 
The single contig genome of isolate CNM10 sequenced by Pacific Biosciences (PacBio) 
technology (Tzeng et al., 2017) was used as the reference genome in variant analysis. 
Polymyxin B resistant derivatives within the zone of inhibitions were recovered from seven 
CNM urethritis isolates (Table 1) were sequenced by MiSeq, yielding ~200X coverage of 
paired end 250-bp reads, assembled using SPAdes (Bankevich et al., 2012) and annotated by 
RAST(Aziz et al., 2008). The variant analysis service provided at www.patricbrc.org was 
utilized with the BWA-men (Li & Durbin, 2009) and SAMtools (Li et al., 2009) programs as 
the aligner and the SNP caller, respectively. The Illumina raw reads of the mutants were 
analyzed against a complete CNM10 genome as the reference. In addition, the assembled 
contigs were compared to the reference CNM10 genome using the genome comparator tool 
available at the PUBMLST site (www.pubmlst.org) to identify allele differences. Variants 
were further confirmed by targeted PCR amplification and sequencing.
Construction of lptA, mtrD/E, pilM, pilQ, and mutL mutants
The CNM3 isolate was transformed with pKA314 (Tzeng et al., 2004) to generate the 
lptA::Ω(Sp) mutant, CNM3A. The mtrE:: Ω(Kn) mutation was PCR amplified from the 
M7mtrE mutant with primers mrtDF2-ER and mtrE3R1-ER and the mtrD:: Ω(Sp) mutation 
from strain XZ134 (Tzeng et al., 2005) using primers mtrCF1 and mtrE3R1-ER. The 
purified PCR products were then used to transform CNM3. The lptA/mtrE double mutant, 
CNM3EA, was subsequently generated by transforming the mtrE mutant with pKA314. A 
PCR product with the mutL::Ω(Sp) mutation was obtained with primers mutL1a and mutL1b 
(Richardson & Stojiljkovic, 2001) and used to transform the CNM3 isolate.
The pilM::aphA3 mutation was created by the overlapping PCR method. Primer pairs of 
YT113 and pilM-5Ra and primer pairs of pilM-3Fa and pilMR2 were used to generate 
5,627-bp and 3,460-bp fragments, respectively. The aphA3(Kn) cassette was amplified using 
primers aphA3-SmF and aphA3-SmR. First overlapping PCR was performed with the 
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aphA3 cassette and the 3’ fragment and then the resulting product was used for the second 
overlapping with the 5’ fragment. The resulting construct deleted 756-bp pilM sequence.
To introduce the pilQ point mutations found in the PmB heteroresistant mutants 14R2 and 
17R1, a construct with aphA3 cassette inserted 25 bp downstream of the pilQ stop codon 
was created by overlapping PCR. Primers pilQ-F1 and pilQ-5RA3 were used to amplify an 
1144-bp 5’ fragment from chromosomal DNAs of isolate 14R2 and 17R1 that carries the 
respective point mutations. The first overlapping PCR combined the 5’ fragment with the 
aphA3 cassette and the resulting product was subsequently used for overlapping PCR with a 
3’ 849-bp fragment of primers pilQ-3FA3 and pilQ-3R2. The final ~2.8 kb product was used 
to transform either the CNM14 or CNM17 parental isolates as well as the CNM3 isolate and 
kanamycin resistant colonies were saved. PCR products were generated from the colonies 
and sequenced to determine whether the point mutations were recombined into the 
transformants. Transformants with the desired point mutations or with a wild type sequence 
were saved for comparison. The CNM3DQ and CNM3AQ mutants were created by 
transformation of strains CNM3D and CNM3A with the overlapping PCR products carrying 
the 14R2 pilQ mutation.
Determination of spontaneous mutation and slipped strand mispairing frequencies
Overnight GC plate cultures were resuspended in GC broth and standardized by the OD550 
readings. For spontaneous mutation rates, 40 μl of serial dilutions of cell suspensions were 
spotted onto GC plates for total CFU counts. Approximately 1010 cells were plated onto GC 
plates containing 3 μg rifampin/ml (Richardson & Stojiljkovic, 2001). Spontaneous rifampin 
mutation rates were obtained as the ratio of rifampin-resistant cells to the total number of 
cells. Serial dilutions of UROS-containing strains were plated on non-selective GC plates for 
total counts and on selective (60 μg/ml spectinomycin) plates for switch-on CFU counts. 
Frequencies of phase variation were determined as described previously (Alexander et al., 
2004b) and are represented as medians of three independent measurements.
Transformation efficiency
Plate-grown meningococcal strains were suspended in GC broth supplemented with 5 mM 
MgCl2. One μg of chromosomal DNA (tonB::ΩSp) from Nm strain NMB was added to 
aliquots (100 μl) of cell suspension at an OD550 of 1 and then incubated for 1 hr at 37oC. 
Pre-warmed GC broth with complete supplements (500 μl) and DNase I (2 units) was added 
and the incubation continued for another 30 minutes. Serial dilutions were made and 
aliquots of 50 μl were spotted onto non-selective GC plates and the colony forming units 
(cfu) determined after overnight growth. 500-μl of the transformation mixtures and 100-μl 
aliquots of 10−1 and 10−2 dilutions of the mutants and the parental strains, respectively, were 
plated onto selective (Sp) plates. The efficiencies were calculated as the ratio of cfu/ml from 
the selection plate to the cfu/ml of non-selective plates.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
(A) E-test pictures of two US_NmUC isolates (CNM3 and CNM8), two non-encapsulated 
Nm reference strains (M7 and FM7) and Ng reference strains GA1090. The arrow points to 
a heteroresistant colony in the zone of growth inhibition. (B) Population analysis profiling 
(PAP) assays of PmB with strains M7 (□), CNM3 (■), CNM8 (○), FM7 (◆) and FA1090 
(●). The CFU counts of plates without PmB were set as 100% for normalization. The dotted 
line indicates the limit of detection. Each PmB concentration was assayed in triplicate and 
the experiments were repeated at least three times. (C) PAP assays of colistin performed 
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similarly to PmB PAP assays with strains CNM3 (■), PmB heteroresistant mutant 3R4 (○), 
FM7 (◆), M7 (□) and FA1090 (●). Each concentration was tested in duplicates and the 
assays repeated twice.
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Figure 2. 
Sensitivity to LL-37 of the CNM3 clade isolate (gray) and its heteroresistant mutant 3R4 
(black). Bacterial cells were incubated with LL-37 in RPMI at the indicated concentrations 
for 30 min and the number of viable CFU were determined by plating onto GC agar plates. 
Each conditions were assayed in duplicate at least twice. The averages and standard 
deviations of two independent assays are presented. Student’s t test was used to determine 
the statistical significance of survival of the mutant with respect to that of the wild type 
strain (**, P < 0.01).
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Figure 3. 
PilQ expression determined by Western blots. Equal amounts of whole cell lysates were 
resolved on 8% SDS-PAGE gels and transferred to PVDF membranes. The membrane was 
probed with PilQ antisera (Tonjum et al., 1998). Lanes: 1, WT; 2, 3R4 (pilQ-frameshift); 3, 
37R1 (pilM::IS1655); 4, 45R2 (pilM-frameshift); 5, 14R2 (pilQ/T756P); 6, 17R1 (pilQ/
T489P); 7, 32R1 (pilQ-frameshift); 8, 33R1 (pilQ-frameshift); 9, WT. The locations of PilQ 
multimer and monomer were marked on the right. Protein MW ladders were labeled on the 
left.
Tzeng et al. Page 22
Mol Microbiol. Author manuscript; available in PMC 2019 December 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 4. 
(A) Population analysis profiling (PAP) assays of PmB resistance. Strains CNM3 (■), its 
mutL (CNM3L, ◆) and mtrD (CNM3D, ●) mutants and the mutator strain IR2855 (○) 
were compared. The CFU counts of plates without PmB were set as 100% for normalization. 
Each PmB concentration was assayed in triplicate and the experiments were repeated at least 
three times. The dotted line indicates the limit of detection. (B) PAP assays of colistin 
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resistance. Strains CNM3 (■), its mutL (CNM3L, ◆), mtrD (CNM3D, ●) and 
heteroresistant mutant 3R4 (○) were examined analogously to the PmB PAP assays.
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Table 1.
Polymyxin resistant mutants derived from the US_NmUC isolates
Mutant PmB MIC (parental) Gene Position Changesa Parent/mutant Outcomeb Transformation frequencyc (parental)
3R3, 3R4, 
3R5, 3R6, 
3R7
1,024
(128)
pilQ T167 ctTcg/ctcg fs F56S* <1.3×10−8
(3.4×10−4)
14R2 1,024
(192)
pilQ A2266 acc/Ccc T756P <4.9×10−9
(1.9×10−5)
17R1 1,024
(128)
pilQ A1465 acc/Ccc T489P 3.2×10−7
(2.1×10−5)
32R1, 32R2 1,024
(128)
pilQ G2229 ggg/gggG fs G743 → 815 aa <1.4×10−8
(4.1×10−5)
33R1 1,024
(96)
pilQ A1947 Aaaaaa/aaaaa fs AVLG/PSWG 655* 1.3×10−7
(2.2×10−5)
37R1 384
(96)
pilM A16 IS1655 insertion Disruption <3.9×10−8
(3.6×10−5)
45R2 384
(128)
pilM C126 caa/Taa fs Q43* <7.2×10−9
(7.9×10−5)
a:
For point mutation, the wildtype sequence is shown on the left and the mutant on the right. The changed nucleotide was in capital letter.
b:Amino acid changes from the wild type to the mutant and the residue number are indicated. An asterisk indicates a stop codon immediately 
following the residue. The frameshift in 32R1 and 32R2 removed the original stop codon and yielded a larger PilQ protein. The lengths of PilQ and 
PilM proteins are 769 and 371, respectively.
c:
Transformation was performed using 1 μg chromosomal DNA carrying a tonB::Ω(Sp) mutation. Frequencies (n=3) were calculated as the ratio of 
SpR cfu/ml to total cfu/ml per 1 μg DNA. The mutants with numbers in bold were transformable at low frequencies; while no transformants were 
recovered from the others.
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Table 2.
Comparison of antibiotic resistance levels of the PmB heteroresistant mutant#
Antibiotics
CNM3 CNM3R4 MS11 CNG20 FA19
E test (μg/ml)
Colistin 53.3 ± 9.2 256** 256 48 32
Penicillin G 0.22 ± 0.08 0.46 ± 0.10** 0.25 0.064 0.012
ceftriaxone 0.002 ± 0.000 0.004 ± 0.001** 0.002 0.002 0.002
Cefotaxime 0.01 ± 0.003 0.021 ± 0.004** 0.012 0.004 0.002
Azithromycin 0.70 ± 011 0.85 ± 0.14 0.19 0.032 0.064
Streptomycin 7.8 ± 0.7 10.9 ± 2.0** 1024 4 6
Kanamycin 10.9 ± 2.0 14.3 ± 2.1** 8 8 4
Chloramphenicol 0.63 ± 0.13 0.81 ± 0.18* 2 0.125 0.25
Meropenem 0.3 ± 0.1 0.3 ± 0.1 0.064 0.094 0.064
Tetracycline 0.19 ± 0.0 0.26 ± 0.1* 0.5 0.25 0.094
Levofloxacin 0.008 ± 0.0 0.007 ± 0.0 0.004 0.002 0.003
#.
Data are presented as the mean ± standard deviation (N=3–8). The MIC values of antibiotics in bold are statistically different between CNM3 and 
3R4 by student’s t test (**, p < 0.01; *, p < 0.05). A single data point is shown for each gonococcal strain as comparison.
Mol Microbiol. Author manuscript; available in PMC 2019 December 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Tzeng et al. Page 27
Table 3.
Comparison of antibiotic resistance levels of the PmB heteroresistant derivative in the mtrD or lptA mutant 
background
Antibiotics
CNM3D CNM3DQ CNM3A CNM3AQ
E test (μg/ml)
Penicillin G 0.053 ± 0.01 0.058 ± 0.01 0.079 ± 0.021 0.115 ± 0.018
Chloramphenicol 0.38 ± 0.0 0.38 ± 0.0 0.38 ± 0.0 0.38 ± 0.0
Tetracycline 0.182 ± 0.151 0.115 ± 0.018 0.094 ± 0.0 0.084 ± 0.017
#.
Data are presented as the mean ± standard deviation (n=3).
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Table 4.
Bacterial strains used in this study.
Strains Description Source
IR2781 N. meningitidis serogroup B strain NMB (Richardson & Stojiljkovic, 2001)
FM7 Non-encapsulated N. meningitidis serogroup C strain FAM18 This study
M7 Non-encapsulated serogroup B strain IR2781 (Swartley & Stephens, 1994)
GA18736 N. meningitidis serogroup W 2002 clinical isolate Laboratory collection
IR2855 N. meningitidis serogroup A clinical isolate (Richardson & Stojiljkovic, 2001)
IR5426 hpuB::UROS derivative of IR2855 (Alexander et al., 2004b)
CNM3 N. meningitidis US_NmUC isolate (Tzeng et al., 2017)
CNM8 N. meningitidis US_NmUC isolate (Tzeng et al., 2017)
CNM3uros hpuB::UROS derivative of CNM3 This study
3R4 N. meningitidis PmB heteroresistant derivative of CNM3 This study
14R2 N. meningitidis PmB heteroresistant derivative of CNM14 This study
17R1 N. meningitidis PmB heteroresistant derivative of CNM17 This study
32R1 N. meningitidis PmB heteroresistant derivative of CNM32 This study
32R2 N. meningitidis PmB heteroresistant derivative of CNM32 This study
33R1 N. meningitidis PmB heteroresistant derivative of CNM33 This study
37R1 N. meningitidis PmB heteroresistant derivative of CNM37 This study
45R2 N. meningitidis PmB heteroresistant derivative of CNM45 This study
CNM3–14R2 N. meningitidis pilQ mutation of 14R2 incorporated into CNM3 This study
CNM3–17R1 N. meningitidis pilQ mutation of 17R1 incorporated into CNM3 This study
CNM3L N. meningitidis CNM3/mutL::aphA3 This study
CNM3E N. meningitidis CNM3 with mtrE:: Ω(Kn) mutation This study
CNM3D N. meningitidis CNM3 with mtrD::Ω(Sp) mutation This study
CNM3A N. meningitidis CNM3 with lptA:: Ω(Sp) mutation This study
CNM3EM N. meningitidis CNM3E with pilM:: aphA3 mutation This study
CNM3DQ N. meningitidis with the pilQ mutation of 14R2 incorporated into CNM3D This study
CNM3AQ N. meningitidis with the pilQ mutation of 14R2 incorporated into CNM3A This study
FA1090 N. gonorrhoeae reference strain Laboratory collection
FA19 N. gonorrhoeae reference strain Laboratory collection
CNG20 N. gonorrhoeae urethritis isolate (Tzeng et al., 2017)
H041 MDR N. gonorrhoeae clinical isolate (Ohnishi et al., 2011)
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